Omada Health Overview
Latest ROE for Omada Health: 4.14% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow4.14%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for OMDA is 4.14%. That is above the sector sector average of -5.68%. Investors often review this figure alongside Omada Health's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, OMDA currently prints 4.14% for ROE, while the sector average sits near -5.68%. That is roughly 172.8% above the sector mean. Large gaps often invite a closer look at Omada Health's growth, margins, and balance sheet.
Return on Equity shows how effectively Omada Health converts resources into returns. At 4.14%, OMDA may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting OMDA's ROE (4.14%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
